American Research Journal of Dermatology

 Radiodermatitis can cause a real discomfort for patients and can lead to the cessation of the treatment. The aim of our study was to identify different factors regulating acute radiodermatitis. Material and Methods: From January 2016 to December 2017, We conducted a prospective trial with collaboration of dermatologist and radiotherapist of hassan II hospital in Fez. Results: Radiodermatitis stage 1 were found in 20%. The predominent irradiated area in this stage was face and neck in 42% and breast in 27%. Radiodermatitis stage 2 were seen in 40%. 41% in head and neck and 24% in the breast. Radiodermatitis stage 3 were found in 23%. Radidermatitis STAGE 3 were seen only in 3 areas : perineal area (59%), face and neck (22%), breast (19%). Radiodermatitis stage 4 in 17% seen only in 2 areas : perineal 72%, face and neck in 27%. Conclusion: Radiodermatitis is one of the most common side effects experienced by patients undergoing radiotherapy. In our study the factors influencing radiodermatitis were age of the patient, sexe, obesity, smoking, perineal location, photoexposed areas, higher radiation doses.

: Acute radiodermatitis, regulating factors, Radiotherapy side effects